Equibles does not estimate personal net worth.
Get an email with a short summary when Champions Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get CSBR alertsDavid Miller is recorded as CFO at Champions Oncology, Inc. (CSBR). The proxy statement of Champions Oncology, Inc. reports total compensation of $388,464 for David Miller in fiscal 2026, including a base salary of $315,000. Disclosed compensation is on record for 8 fiscal years. David Miller has spoken on 24 earnings calls across 1 company, most recently for Champions Oncology, Inc. on March 12, 2026. Champions Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Champions Oncology, Inc. includes Robert Brainin (CEO and Board Member), Ronnie Morris (Chairman), Brian Alexander (Board Member) and 5 others.
“Total revenue for the core $15 million in a prior year period, a decrease of approximately 32%. We do not recognize any data revenue from our nascent data platform this quarter, compared to $4.5 million in a prior contributor to our results over time.”
“Before I dive in, as a quick reminder that our full results will be filed on Form 10-Q with the SEC later today. And as always, I'll reference certain non-GAAP metrics with reconciliations to GAAP included in our earnings release.”
“Before I dive in, just a quick reminder that our full results will be filed on Form 10-Q with the SEC later today. And as always, I'll reference certain non-GAAP metrics with reconciliations to GAAP included in our earnings release.”
“Our full results on Form 10-Q will be filed with the SEC by Monday, March 17th. As Ronnie highlighted, we had a record breaking quarter with total revenue surpassing $17 million and adjusted EBITDA hitting a record high.”
“Our full results on Form 10-Q will be filed with the SEC by Monday, December 16. As we've been highlighting, the financial rebound that began in the final quarter of 2024 has continued through our second quarter with revenue of $13.5 million, a 17% increase over the same period last year.”
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $315,000 | $388,464 |
| 2025 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $278,333 | $315,777 |
| 2024 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $260,000 | $260,000 |
| 2023 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $260,000 | $294,303 |
| 2022 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $260,000 | $321,538 |
| 2021 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $250,000 | $311,681 |
| 2020 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $250,000 | $372,915 |
| 2019 | Champions Oncology, Inc. (CSBR) | Chief Financial Officer | $250,000 | $275,000 |
